Laurysens (BENE, Vrije Universiteit Brussel, Brussels, Belgium) and J
Fortunately, pharmaceutical companies like Eli Lilly and Novo Nordisk offer savings options for patients but only if they already have commercial insurance coverage
Diabetes Obes Metab 25(5):13851397 Amaro A, Sugimoto D, Wharton S (2022) Efficacy and safety of semaglutide for weight management: evidence from the STEP program
Oral GLP-1 medications reduce some barriers associated with injectable administration particularly convenience and needle aversion and may broaden uptake among patients who previously declined injectable therapy
Statins These cholesterol-lowering drugs are often prescribed for the primary and secondary and primary prevention of coronary artery disease
Recognizing the underlying causes and implementing targeted strategies helps patients safely continue therapy while minimizing symptoms